Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 4020253, 2 pages
https://doi.org/10.1155/2017/4020253
Editorial

Oxidants and Redox Signaling: Perspectives in Cancer Therapy, Inflammation, and Plasma Medicine

1ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP Greifswald), Greifswald, Germany
2Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
3Department for Neurology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany

Correspondence should be addressed to Sander Bekeschus; ed.dlawsfierg-pni@suhcsekeb.rednas

Received 17 August 2017; Accepted 17 August 2017; Published 29 October 2017

Copyright © 2017 Sander Bekeschus et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Sander Bekeschus, Lars Bräutigam, Kristian Wende, and Eva-Maria Hanschmann, “Oxidants and Redox Signaling: Perspectives in Cancer Therapy, Inflammation, and Plasma Medicine,” Oxidative Medicine and Cellular Longevity, vol. 2017, Article ID 4020253, 2 pages, 2017. https://doi.org/10.1155/2017/4020253.